Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,509-2,520 of 4,306
Drug study icon
CompletedNCT00488319

Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

This study is completed in the United States, in Belgium, in Bulgaria, .... It focuses on schizophrenia.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 12 Years to 17 Years
Countries
United States, Belgium, Bulgaria, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
TerminatedNCT02144155

Study of the Efficacy of Intranasal Oxytocin in Schizophrenia

This study was terminated in the United States. It is testing efficacy of Intranasal Oxytocin for schizophrenia.

In San Diego
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Device study icon
CompletedNCT02219009

Usability of the Medical Information Device #1 System for schizophrenia

This study is completed in the United States. It is testing Usability of the Medical Information Device #1 System for schizophrenia.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01683058

Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in people with Schizophrenia

This study is completed in the United States, in Croatia, and in Latvia. It is testing Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 66 Years
Countries
United States, Croatia, Latvia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01001702

Oral Aripiprazole Rollover Study

This study is completed in Argentina, in Croatia, in India, .... It focuses on Schizophrenia.

Multiple locations, including Buenos Aires
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 18 Years
Countries
Argentina, Croatia, India, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
WithdrawnNCT00425815

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
Drug study icon
TerminatedNCT00506909

Oxytocin Add on Study for Stable Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
David Feifel
Condition
Schizophrenia
Drug study icon
CompletedNCT00884897

Oxytocin and Social Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Catonsville
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, AnxietyDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia, Anxiety
Drug study icon
CompletedNCT01699997

Oxytocin as Adjunctive Therapy for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Urbino
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 45 Years
Countries
Italy
Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Condition
Schizophrenia
Drug study icon
CompletedNCT01568528

Oxytocin as Adjunctive Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Decatur
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
Drug study icon
CompletedNCT02568709

Oxytocin MEG Study

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Schizophrenia
Other study type icon
TerminatedNCT01244542

Pain and Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Besançon
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.